16Jan/14

FDA to Evaluate Idelalisib for Indolent Non-Hodgkin's Lymphoma – Monthly Prescribing Reference

FDA to Evaluate Idelalisib for Indolent Non-Hodgkin’s Lymphoma
Monthly Prescribing Reference
The NDA submission was supported by a single arm Phase 2 study (Study 101-09) evaluating idelalisib in patients with iNHL that is refractory (non-responsive) to rituximab and to alkylating-agent-containing chemotherapy. Idelalisib is an investigational
FDA Approves Application Review For Refractory Indolent Non-Hodgkin’s BioResearch Online (press release)

all 2 news articles »

16Jan/14

Nomura Reiterates Bullish View on Biogen (BIIB) on Tecfidera Sales – StreetInsider.com (subscription)

Nomura Reiterates Bullish View on Biogen (BIIB) on Tecfidera Sales
StreetInsider.com (subscription)
“We remain focused on daclizumab Phase III MS data in mid-2014 given its $2bn revenue opportunity and anti-LINGO Phase II optic neuritis data in 4Q14, given its read through to the MS trial (2015E). In a year of regulatory and commercial execution, we 

16Jan/14

Organ donation too important to be used as a political football, says mother … – Belfast Telegraph


Belfast Telegraph

Organ donation too important to be used as a political football, says mother
Belfast Telegraph
To save her life she received a liver transplant within three days – because Spain has an ‘opt-out’ for organ donation. Everyone is regarded to have given consent to be an organ donor after death unless they state otherwise and opt out. Sadly, she died